
CBT for insomnia did not reliably improve complete benzodiazepine or Z-drug discontinuation
AI-summarized from the linked source. Educational brief, not medical advice.
Brief summary
A systematic review of randomized trials found no high-certainty evidence that adding cognitive behavioral therapy for insomnia reliably improves complete benzodiazepine-receptor-agonist or Z-drug discontinuation, although it may support insomnia coping during individualized tapering.
What NurseJet pulled from the source
Across 13 trials, early complete discontinuation favored CBT-I-assisted care but was uncertain (6 trials, 298 participants; RR 1.35, 95% CI 0.87 to 2.11). Post-treatment insomnia severity was lower with CBT-I in three small trials, while long-term discontinuation evidence was highly uncertain.
Why this matters for nurses
Nurses often identify long-term sedative-hypnotic use, falls, cognitive effects, withdrawal concerns, and rebound insomnia. The review supports presenting CBT-I as a possible aid within a supervised deprescribing plan, not as a guarantee of medication discontinuation.
Bedside takeaway
Use CBT-I as a possible support within supervised deprescribing, not as a promise of complete sedative-hypnotic discontinuation.
Key takeaways
- The pooled early-discontinuation estimate did not establish a reliable benefit because its confidence interval included no difference and heterogeneity was substantial.
- Complete discontinuation at the longest follow-up was highly uncertain, and dose-reduction results could not be pooled because definitions and time points varied.
- CBT-I-assisted interventions lowered post-treatment insomnia-severity scores in three small trials, but the evidence remained uncertain.
Practice implications
- Reconcile benzodiazepine and Z-drug use, duration, and fall or cognitive concerns; avoid abrupt discontinuation; and route tapering and CBT-I questions to the prescribing and behavioral-health team. Reinforce the individualized plan and monitor for withdrawal or worsening insomnia according to local protocol.
Limitations & cautions
- The included trials were small and heterogeneous, long-term estimates were imprecise, dose-reduction definitions varied, and safety reporting was incomplete. The review does not establish a single CBT-I or tapering protocol.
- AI-summarized from the linked source. Review the original article before applying to practice.
Citations
Exact source links
Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.
Journal of International Medical Research (PubMed)
Journal of International Medical Research (PubMed). Cognitive behavioral therapy for insomnia-assisted discontinuation or reduction of benzodiazepine receptor agonists and Z-drugs in chronic insomnia: A systematic review and meta-analysis.
https://pubmed.ncbi.nlm.nih.gov/42751933/
Professional education only


